This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Enterprise Value of Edwards Lifesciences Corporation with missing and latest data points interpolated. Enterprise Value (or EV) is usually referred to as Edwards Lifesciences theoretical takeover price. In the event of an acquisition, an acquirer would have to take on Edwards Lifesciences debt, but would also pocket its cash. Enterprise Value is more accurate representation of Edwards Lifesciences value then its market capitalization because it takes into account all of Edwards Lifesciences Corporation existing debt. Enterprise value is a measure of the value of a business as a whole, calculated as Market Capitalization plus Total Debt USD minus Cash and Equivalents USD.
|10 Years Trend|
Compare to Other EquitiesAll Fundamental Data
Edwards Lifesciences Enterprise Value Over Time